4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000010
PRESIDENT AND COO sold 22,500 shares at an average $429.25 ($9,658,073)
- PRESIDENT AND COO acquired 22,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,625 | $135.42 | $1,980,518 | 14,625 | I |
| 2025-11-03 | Sale : show line 2 in the form 10b5-1 | −964 | $432.55 | $416,976 | 13,661 | I |
| 2025-11-03 | Sale : show line 3 in the form 10b5-1 | −2,687 | $433.52 | $1,164,868 | 10,974 | I |
| 2025-11-03 | Sale : show line 4 in the form 10b5-1 | −2,918 | $434.68 | $1,268,407 | 8,056 | I |
| 2025-11-03 | Sale : show line 5 in the form 10b5-1 | −3,204 | $435.52 | $1,395,391 | 4,852 | I |
| 2025-11-03 | Sale : show line 6 in the form 10b5-1 | −2,121 | $436.45 | $925,707 | 2,731 | I |
| 2025-11-03 | Sale : show line 7 in the form 10b5-1 | −890 | $437.70 | $389,551 | 1,841 | I |
| 2025-11-03 | Sale : show line 8 in the form 10b5-1 | −585 | $438.34 | $256,427 | 1,256 | I |
| Open-market sales · 22,500 sh · avg $429.25 · $9,658,073 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Options | −14,625 | $135.42 | 2026-03-15 | 14,625 | 41,250 | I |
| 2025-11-03 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Options | −7,875 | $146.03 | 2026-03-15 | 10,500 | 10,500 | I |
Loading xslF345X05/primarydocument.xml…